CMPS
COMPASS Pathways plc
Medical - Care Facilities
Market Cap$938M
5Y Perf.-74.4%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
CMPS vs ATAI
Revenue, margins, valuation, and 5-year total return — side by side.
ATAI
Atai Beckley N.V
Medical - Pharmaceuticals
Market Cap$1.00B
5Y Perf.-77.5%
CMPS vs ATAI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | CMPS | ATAI |
|---|---|---|
| Industry | Medical - Care Facilities | Medical - Pharmaceuticals |
| Market Cap | $938M | $1.00B |
| Revenue (TTM) | $0.00 | $3M |
| Net Income (TTM) | $-288M | $-154M |
| Gross Margin | — | -259.1% |
| Operating Margin | — | -34.6% |
| Total Debt | $21M | $25M |
| Cash & Equiv. | $150M | $18M |
CMPS vs ATAI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
CMPS
ATAI
| Stock | Jun 21 | May 26 | Return |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | 100 | 25.6 | -74.4% |
| Atai Beckley N.V (ATAI) | 100 | 22.5 | -77.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CMPS vs ATAI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: ATAI leads in 3 of 6 categories, making it the strongest pick for growth and revenue expansion and recent price momentum and sentiment. COMPASS Pathways plc is the stronger pick specifically for profitability and margin quality and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
CMPS
COMPASS Pathways plc
The Income Pick
CMPS is the clearest fit if your priority is income & stability and growth exposure.
- beta 1.33
- EPS growth -33.9%
- Lower volatility, beta 1.33, current ratio 0.77x
Best for: income & stability and growth exposure
ATAI
Atai Beckley N.V
The Long-Run Compounder
ATAI carries the broadest edge in this set and is the clearest fit for long-term compounding.
- -46.9% 10Y total return vs CMPS's -66.3%
- -1.9% revenue growth vs CMPS's -85.7%
- +202.2% vs CMPS's +167.4%
Best for: long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | ATAI | -1.9% revenue growth vs CMPS's -85.7% |
| Quality / Margins | CMPS | 1.3% margin vs ATAI's -51.1% |
| Stability / Safety | CMPS | Beta 1.33 vs ATAI's 1.48 |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | ATAI | +202.2% vs CMPS's +167.4% |
| Efficiency (ROA) | ATAI | -64.3% ROA vs CMPS's -106.8% |
CMPS vs ATAI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2024
CMPS vs ATAI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLCMPSLAGGINGATAI
ATAIAtai Beckley N.V
2leads
CMPSCOMPASS Pathways plc
2leads
6 Total Categories
CATEGORYLEADERvs ATAIMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
CMPS1/1
Valuation MetricsMultiples, price ratios, and targets
ATAI1/1
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
Tied
—
Total Returns1Y, 3Y, 5Y total returns with dividends
ATAI4/6
Risk & VolatilityBeta, volatility, and downside exposure
CMPS2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
CMPS leads this category, winning 1 of 1 comparable metric.
Income & Cash Flow (Last 12 Months)
ATAI and CMPS operate at a comparable scale, with $3M and $0 in trailing revenue.
| Metric | CMPSCOMPASS Pathways … | ATAIAtai Beckley N.V |
|---|---|---|
| RevenueTrailing 12 months | $0 | $3M |
| EBITDAEarnings before interest/tax | -$179M | -$103M |
| Net IncomeAfter-tax profit | -$288M | -$154M |
| Free Cash FlowCash after capex | -$157M | -$90M |
| Gross MarginGross profit ÷ Revenue | — | -2.6% |
| Operating MarginEBIT ÷ Revenue | — | -34.6% |
| Net MarginNet income ÷ Revenue | — | -51.1% |
| FCF MarginFCF ÷ Revenue | — | -29.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +17.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -58.7% | -75.0% |
CMPS leads this category, winning 1 of 1 comparable metric.
Valuation Metrics
ATAI leads this category, winning 1 of 1 comparable metric.
Valuation Metrics
| Metric | CMPSCOMPASS Pathways … | ATAIAtai Beckley N.V |
|---|---|---|
| Market CapShares × price | $938M | $1.0B |
| Enterprise ValueMkt cap + debt − cash | $809M | $1.0B |
| Trailing P/EPrice ÷ TTM EPS | -3.17x | -4.48x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | — | 3255.27x |
| Price / BookPrice ÷ Book value/share | — | 5.73x |
| Price / FCFMarket cap ÷ FCF | — | — |
ATAI leads this category, winning 1 of 1 comparable metric.
Profitability & Efficiency
Evenly matched — CMPS and ATAI each lead in 3 of 6 comparable metrics.
Profitability & Efficiency
ATAI delivers a -96.4% return on equity — every $100 of shareholder capital generates $-96 in annual profit, vs $-3 for CMPS.
| Metric | CMPSCOMPASS Pathways … | ATAIAtai Beckley N.V |
|---|---|---|
| ROE (TTM)Return on equity | -3.4% | -96.4% |
| ROA (TTM)Return on assets | -106.8% | -64.3% |
| ROICReturn on invested capital | — | -45.0% |
| ROCEReturn on capital employed | -2.5% | -50.4% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 2 |
| Debt / EquityFinancial leverage | — | 0.21x |
| Net DebtTotal debt minus cash | -$129M | $7M |
| Cash & Equiv.Liquid assets | $150M | $18M |
| Total DebtShort + long-term debt | $21M | $25M |
| Interest CoverageEBIT ÷ Interest expense | -52.40x | -68.93x |
Evenly matched — CMPS and ATAI each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
ATAI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CMPS five years ago would be worth $2,816 today (with dividends reinvested), compared to $2,097 for ATAI. Over the past 12 months, ATAI leads with a +202.2% total return vs CMPS's +167.4%. The 3-year compound annual growth rate (CAGR) favors ATAI at 27.5% vs CMPS's 4.9% — a key indicator of consistent wealth creation.
| Metric | CMPSCOMPASS Pathways … | ATAIAtai Beckley N.V |
|---|---|---|
| YTD ReturnYear-to-date | +49.0% | +7.8% |
| 1-Year ReturnPast 12 months | +167.4% | +202.2% |
| 3-Year ReturnCumulative with dividends | +15.4% | +107.5% |
| 5-Year ReturnCumulative with dividends | -71.8% | -79.0% |
| 10-Year ReturnCumulative with dividends | -66.3% | -46.9% |
| CAGR (3Y)Annualised 3-year return | +4.9% | +27.5% |
ATAI leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
CMPS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CMPS is the less volatile stock with a 1.33 beta — it tends to amplify market swings less than ATAI's 1.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CMPS currently trades 95.6% from its 52-week high vs ATAI's 61.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | CMPSCOMPASS Pathways … | ATAIAtai Beckley N.V |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.33x | 1.48x |
| 52-Week HighHighest price in past year | $10.21 | $6.75 |
| 52-Week LowLowest price in past year | $2.25 | $1.29 |
| % of 52W HighCurrent price vs 52-week peak | +95.6% | +61.8% |
| RSI (14)Momentum oscillator 0–100 | 65.2 | 46.6 |
| Avg Volume (50D)Average daily shares traded | 3.7M | 6.0M |
CMPS leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates CMPS as "Buy" and ATAI as "Buy". Consensus price targets imply 187.8% upside for ATAI (target: $12) vs 82.7% for CMPS (target: $18).
| Metric | CMPSCOMPASS Pathways … | ATAIAtai Beckley N.V |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $17.83 | $12.00 |
| # AnalystsCovering analysts | 13 | 4 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
CMPS leads in 2 of 6 categories (Income & Cash Flow, Risk & Volatility). ATAI leads in 2 (Valuation Metrics, Total Returns). 1 tied.
Best OverallCOMPASS Pathways plc (CMPS)Leads 2 of 6 categories
Loading custom metrics...
CMPS vs ATAI: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is CMPS or ATAI a better buy right now?
Analysts rate COMPASS Pathways plc (CMPS) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison.
The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — CMPS or ATAI?
Over the past 5 years, COMPASS Pathways plc (CMPS) delivered a total return of -71.
8%, compared to -79. 0% for Atai Beckley N. V (ATAI). Over 10 years, the gap is even starker: ATAI returned -46. 9% versus CMPS's -66. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — CMPS or ATAI?
By beta (market sensitivity over 5 years), COMPASS Pathways plc (CMPS) is the lower-risk stock at 1.
33β versus Atai Beckley N. V's 1. 48β — meaning ATAI is approximately 11% more volatile than CMPS relative to the S&P 500.
04Which is growing faster — CMPS or ATAI?
On earnings-per-share growth, the picture is similar: COMPASS Pathways plc grew EPS -33.
9% year-over-year, compared to -272. 0% for Atai Beckley N. V. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — CMPS or ATAI?
COMPASS Pathways plc (CMPS) is the more profitable company, earning 0.
0% net margin versus -484. 6% for Atai Beckley N. V — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CMPS leads at 0. 0% versus -333. 4% for ATAI. At the gross margin level — before operating expenses — ATAI leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — CMPS or ATAI?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is CMPS or ATAI better for a retirement portfolio?
For long-horizon retirement investors, COMPASS Pathways plc (CMPS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding.
Both have compounded well over 10 years (CMPS: -66. 3%, ATAI: -46. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between CMPS and ATAI?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.